---

David Dunger

Professor of Pediatrics, University of Cambridge

David Dunger is a Pediatric Endocrinologist who works closely with industry to develop novel medications for children with diabetes and endocrine disorders. He is an expert on the growth hormone/insulin-like growth factor 1 (IGF-1) axis and its effects on metabolism, and his work in this area has led to the first experimental and clinical studies of recombinant human IGF-1 in type 1 diabetes.

---

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018